Flotek Raises Full-Year Revenue Guidance for 2026
Flotek Industries (NYSE:FTK) has raised its full-year revenue guidance for 2026 to a range of $360 million to $370 million, up from the previous estimate of $340 million to $350 million. The company also increased its Adjusted EBITDA forecast to between $50 million and $54 million, compared with an earlier projection of $47 million to $51 million. The revision follows a significant increase in international chemistry sales during the second quarter of 26, which reached approximately $10.6 million—more than four times higher than the first-quarter figure. Flotek anticipates that these international sales could exceed $40 million in the latter half of the year, driven by activity in Saudi Arabia. CEO Dr. Ryan Ezell attributed the upward revision to growing demand for its products and expressed confidence in achieving strong growth compared with 2025 results.
Tickers: $FTK
Topics: EBITDA guidance international sales revenue